X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/cali-biosciences-initiates-second-phase-iii-study-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-and-presents-consistent-and-predictable-pk-results-across-multiple-surgeries-301841948.html
https://www.prnewswire.com/news-releases/cali-biosciences-initiates-phase-iii-studies-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-301801255.html